BioRem Inc. (TSXV:BRM)
| Market Cap | 61.15M +89.8% |
| Revenue (ttm) | 50.70M +32.2% |
| Net Income | 6.22M +97.7% |
| EPS | 0.34 +107.1% |
| Shares Out | 16.31M |
| PE Ratio | 11.14 |
| Forward PE | 9.74 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,261 |
| Open | 3.710 |
| Previous Close | 3.710 |
| Day's Range | 3.710 - 3.750 |
| 52-Week Range | 2.010 - 3.950 |
| Beta | 0.93 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 18, 2026 |
About BioRem
BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds, and hazardous air pollutants. The company offers biofilters; biotrickling filters; multi-stage systems; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. It also sells biofiltration media products under the BIOSORBENS, XLD, BIOPAK, BIOROLL, and BIOBLOK names. The company operates in Canada, the United States... [Read more]
Financial Performance
In 2025, BioRem's revenue was 42.36 million, an increase of 13.19% compared to the previous year's 37.42 million. Earnings were 4.82 million, an increase of 58.25%.
Financial StatementsNews
BioRem Transcript: Planet MicroCap Showcase: Toronto 2026
YTD bookings neared CAD 50m, backlog exceeded CAD 70m and the active funnel topped CAD 220m. Service revenue reached CAD 4m in H1, supporting a push toward recurring revenue.
BioRem Report: Q2 2026
BioRem published a report on July 28, 2026 containing material business information for investors and shareholders.
BioRem MD&A: Q2 2026
BioRem filed a regulatory document on July 28, 2026 disclosing important business information.
BioRem Earnings release: Q2 2026
BioRem released its Q2 2026 earnings on July 28, 2026, summarizing the period's financial results.
BioRem MD&A: Q1 2026
BioRem filed a regulatory document on May 14, 2026 disclosing important business information.
BioRem Report: Q1 2026
BioRem published a report on May 14, 2026 containing material business information for investors and shareholders.
BioRem Earnings release: Q1 2026
BioRem released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
BioRem MD&A: Q4 2025
BioRem filed a regulatory document on April 20, 2026 disclosing important business information.
BioRem Report: Q4 2025
BioRem published a report on April 20, 2026 containing material business information for investors and shareholders.
BioRem Earnings release: Q4 2025
BioRem released its Q4 2025 earnings on April 20, 2026, summarizing the period's financial results.
BioRem MD&A: Q3 2025
BioRem filed a regulatory document on November 16, 2025 disclosing important business information.
BioRem Report: Q3 2025
BioRem published a report on November 16, 2025 containing material business information for investors and shareholders.
BioRem Earnings release: Q3 2025
BioRem released its Q3 2025 earnings on November 16, 2025, summarizing the period's financial results.
BIOREM Reports Strong First Quarter Financial Results and Continued Growth in Order Backlog
GUELPH, ON , May 28, 2024 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("BIOREM" or "the Company") today announced results for the three month period ended March 31, 2024. BIOREM's complete 2024 first quart...